Cognitive impact of anticholinergic medication in MS: Adding insult to injury?

Cruce, Roxana; Vosoughi, Reza; Freedman, Mark S

Cruce, Roxana; Vosoughi, Reza; Freedman, Mark S.

Afiliación

Cruce R; The Ottawa Hospital Research Institute, Ottawa, Canada; Division of Neurology, MS Clinic, The Ottawa Hospital, Ottawa, Canada; University of Ottawa, The Ottawa Hospital-General Campus, 501 Smyth Road, Ottawa, Ontario, Canada K1H 8L6.
Vosoughi R; The Ottawa Hospital Research Institute, Ottawa, Canada; Division of Neurology, MS Clinic, The Ottawa Hospital, Ottawa, Canada; University of Ottawa, The Ottawa Hospital-General Campus, 501 Smyth Road, Ottawa, Ontario, Canada K1H 8L6.
Freedman MS; The Ottawa Hospital Research Institute, Ottawa, Canada; Division of Neurology, MS Clinic, The Ottawa Hospital, Ottawa, Canada; University of Ottawa, The Ottawa Hospital-General Campus, 501 Smyth Road, Ottawa, Ontario, Canada K1H 8L6. Electronic address: mfreedman@toh.on.ca.

Mult Scler Relat Disord ; 1(4): 156-61, 2012 Oct.

Article en En | MEDLINE | ID: mdl-25877263

Palabras clave

Anticholinergic therapy; Bladder symptoms; Cognition; Drug side effect; Multiple Sclerosis; Symptomatic therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mult Scler Relat Disord Año: 2012 Tipo del documento: Article